Tejas Dhameliya

Dr. Tejas Dhameliya

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
NGNormi D. Gajjar
Normi D. Gajjar
TDTejas Dhameliya
Tejas Dhameliya
GSGaurang Shah
Gaurang Shah

3 September 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
TDTejas Dhameliya
Tejas Dhameliya
HDHiren A. Donga
Hiren A. Donga
PVPunit V. Vaghela
Punit V. Vaghela
BPBhoomi G. Panchal
Bhoomi G. Panchal
DSDipen K. Sureja
Dipen K. Sureja
MCMahesh T. Chhabria
Mahesh T. Chhabria
Metal nanoparticle (MNP)-catalyzed synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds.

Verified
Journal Article
Open access
PDF file
SBSai HS. Boddu
Sai HS. Boddu
PBPrakash Bhagav
Prakash Bhagav
PKPradeep Kumar Karla
Pradeep Kumar Karla
SJShery Jacob
Shery Jacob
MAMansi Dipesh Adatiya
Mansi Dipesh Adatiya
ATAmit K Tiwari
Amit K Tiwari
Polymers have always played a critical role in the development of novel drug delivery systems by providing the sustained, controlled and targeted release of both hydrophobic and hydrophilic drugs. Among the different polymers, polyamides or poly(amino acid)s exhibit distinct features such as good biocompatibility, slow degradability and flexible physicochemical modification. The degradation rates of poly(amino acid)s are influenced by the hydrophilicity of the amino acids that make up the polymer. Poly(amino acid)s are extensively used in the formulation of chemotherapeutics to achieve selective delivery for an appropriate duration of time in order to lessen the drug-related side effects and increase the anti-tumor efficacy. This review highlights various poly(amino acid) polymers used in drug delivery along with new developments in their utility. A thorough discussion on anticancer agents incorporated into poly(amino acid) micellar systems that are under clinical evaluation is included.

5 January 2022 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
TDTejas Dhameliya
Tejas Dhameliya
SCShrddhaba J. Chudasma
Shrddhaba J. Chudasma
TPTanvi M. Patel
Tanvi M. Patel
BDBhavarth P. Dave
Bhavarth P. Dave

4 January 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
KSKashvi C. Shah
Kashvi C. Shah
MSMaitri B. Shah
Maitri B. Shah
SSSakshi J. Solanki
Sakshi J. Solanki
VMVikas D. Makwana
Vikas D. Makwana
DSDipen K. Sureja
Dipen K. Sureja
TDTejas Dhameliya
Tejas Dhameliya

1 March 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AKAsim Kumar
Asim Kumar
TDTejas Dhameliya
Tejas Dhameliya
KSKirti Sharma
Kirti Sharma
KPKrupa A. Patel
Krupa A. Patel
RHRajvi V. Hirani
Rajvi V. Hirani
ABAditi J. Bhatt
Aditi J. Bhatt